Article L.233-8-II of Commercial Law (Code de commerce) and
Article 223-16 of the General Regulation of the French Financial Markets Authority
(AMF – Autorité des Marchés Financiers)

Press release
Avignon, October 7th, 2011

30.09.2011

Total number of outstanding shares forming the capital 5,034,432 ordinary shares under ISIN FR0000054694 1,387,308 preferred shares under ISIN FR0010833251	6,421,740
Total number of outstanding shares forming the capital     with voting rights 5,034,432 ordinary shares under ISIN FR0000054694 0 shares from stock-options under ISIN FR0000054694	5,034,432
Number of shares with double voting rights	86,641
Total number of gross voting rights	5,121,073
Number of shares without voting rights 0 registered shares 2,430 bearer shares in the frame of the liquidity contract	- 2,430
Total number of exercisable voting rights*	5,108,853

*Real number of voting rights = total number of voting rights – number of shares without voting rights

 

If you would like to receive FINANCIAL information about Naturex by e-mail, go to: www.naturex.fr

Naturex has been listed since October 1996 on NYSE Euronext in Paris, compartment B

Number of shares comprising the capital: 6,421,740 5,034,432 ordinary shares (ISIN FR0000054694) 1,387,308 preferred shares (ISIN FR0010833251) Naturex is part of the CAC Small and Gaïa Indexes. Naturex is eligible for "long only" Deferred Settlement Service (SRD). MNEMO: NRX - Reuters: NATU.PA - Bloomberg: NRX: FP

About Naturex
Naturex is the world leader in specialty plant-based ingredients.
The Group, organised around three strategic markets - Food & Beverage, Nutrition & Health and Personal Care -, produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetics industries.
Naturex's head office is based in Avignon. Naturex employs 950 people and has high-performance industrial resources across its 11 industrial sites in Europe (France, Italy, Spain, United Kingdom and Switzerland), in Morocco, the United States, Brazil and Australia. The company draws on its worldwide sales presence through a fully dedicated sales network in 19 countries (France, Italy, Spain, United Kingdom, Belgium, Germany, Switzerland, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, United States, Canada, Brazil and Mexico).

Naturex enjoys the highly favourable underlying trend linked to increasing demand for natural-origin products and provides manufacturers with personalised solutions in order to meet the expectations of the end consumers. The Group's strength lies in its positioning on specific products which constitute niche markets, thanks to strong sourcing capacity and sustained Research & Development.

• Contacts
Jacques Dikansky President and Chief Executive Officer Tel.: +33 (0)4 90 23 96 89 naturex@naturex.com	Thierry Lambert Vice-President Tel.: +33 (0)4 90 23 96 89 t.lambert@naturex.com
Carole Alexandre Investor Relations Tel.: +33 (0)4 90 23 78 28 c.alexandre@naturex.com	Anne Catherine Bonjour Actus Finance Press Relations Tel.: +33 (0)1 53 67 36 93 acbonjour@actus.fr

---